e-Drug3D 327 |
cas 968-81-0 |
CLASS METABOLISM |
ROUTE (list) ORAL |
ATC code |
PK parameters |
Target TARGET ATP-SENSITIVE POTASSIUM CHANNEL OF THE PANCREATIC B-CELL PDB Ligand code = TF9 (link to the list of PDB complexes) Download experimental 3D coordinates of TF9 with added hydrogens |
DrugCentral Sulfonylurea receptor 1, Kir6.2 UNIPROT Q09428 ABCC8 |
Download SDF file | 3-(4-acetylphenyl)sulfonyl-1-cyclohexylurea Formula: Calculated chemical properties: MW 324.40 NB_atoms 22 XLogP 2.21 PSA 89.404 NB_HD 2 NB_HA 6 fsp3 0.47 Lipinski(0=no;1=yes) 1 |
FDA NDA 070753 (pdf not found) INN (ACETOHEXAMIDE) ACETOHEXAMIDE (USL PHARMA) APPROVAL= - YEAR= 0 DISCONTINUED NDA 070754 (pdf not found) INN (ACETOHEXAMIDE) ACETOHEXAMIDE (USL PHARMA) APPROVAL= - YEAR= 0 DISCONTINUED NDA 013378 (pdf not found) INN (ACETOHEXAMIDE) DYMELOR (LILLY) APPROVAL= AP YEAR= 1964 DISCONTINUED NDA 070869 (pdf not found) INN (ACETOHEXAMIDE) ACETOHEXAMIDE (ANI PHARMS INC) APPROVAL= AP YEAR= 1987 DISCONTINUED OBSOLETE NDA 070870 (pdf not found) INN (ACETOHEXAMIDE) ACETOHEXAMIDE (ANI PHARMS) APPROVAL= AP YEAR= 1987 DISCONTINUED NDA 071893 (pdf not found) INN (ACETOHEXAMIDE) ACETOHEXAMIDE (WATSON LABS TEVA) APPROVAL= AP YEAR= 1987 DISCONTINUED NDA 071894 (pdf not found) INN (ACETOHEXAMIDE) ACETOHEXAMIDE (WATSON LABS TEVA) APPROVAL= AP YEAR= 1987 DISCONTINUED |
Other links: |